Telesis Bio Reports First Quarter 2024 Financial Results
09 mai 2024 16h05 HE
|
Telesis Bio
Telesis Bio Reports First Quarter 2024 Financial Results
Telesis Bio Announces Reverse Stock Split
06 mai 2024 16h05 HE
|
Telesis Bio
Telesis Bio Announces Reverse Stock Split
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
18 avr. 2024 09h00 HE
|
Telesis Bio
Telesis Bio Inc. announces strategic focus on mRNA solutions and announces new leadership
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
28 mars 2024 16h05 HE
|
Telesis Bio
SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,...
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
26 févr. 2024 09h15 HE
|
Telesis Bio
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
Telesis Bio Reports Third Quarter 2023 Financial Results
13 nov. 2023 16h22 HE
|
Telesis Bio
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the third quarter...
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
07 nov. 2023 09h00 HE
|
Telesis Bio
SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2023...
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
03 nov. 2023 12h00 HE
|
Telesis Bio
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
28 sept. 2023 15h48 HE
|
Telesis Bio
SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
Telesis Bio Appoints William J. Kullback Chief Financial Officer
29 août 2023 16h05 HE
|
Telesis Bio
SAN DIEGO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, has named William J. Kullback as its Chief Financial...